PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'GENSCRIPT USA INC., 860 Centennial Ave., Piscataway, NJ 08854, USA. Electronic address: sean.taylor@genscript.com.\', \'Cayman Chemical, 1180 E. Ellsworth Road, Ann Arbor, MI 48108, USA.\', \'Cure-Hub, 12655 SW Beaverdam Rd., Beaverton, OR 97005, USA.\', \'FourthWall Testing LLC, 455 9th Street Suite 128, Winter Garden, FL 34787, USA.\', \'DYNEX Technologies, 14340 Sullyfield Circle, Chantilly, VA 20151-1621, USA.\', \'Kaiser Permanente, 1795 A Second Street, Berkeley, CA 94710, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0264-410X(21)01013-610.1016/j.vaccine.2021.07.098
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 34426026
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
is ?:relation_isRelatedTo_publication of
?:title
  • Semi-quantitative, high throughput analysis of SARS-CoV-2 neutralizing antibodies: Measuring the level and duration of immune response antibodies post infection/vaccination.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34426026>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34426026>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all